The codon-optimized human FIX cDNA (co-hFIX) or its hyper-functional codon-optimized version (co-hFIX-R338L) were cloned downstream of a chimeric liver-specific promoter composed on the minimal transthyretin (TTR) promoter in combination with a hepatocyte-specific cis-regulatory module
ثبت نشده
چکیده
Vector constructs The codon-optimized human FIX cDNA (co-hFIX) or its hyper-functional codon-optimized version (co-hFIX-R338L) were cloned downstream of a chimeric liver-specific promoter composed on the minimal transthyretin (TTR) promoter in combination with a hepatocyte-specific cis-regulatory module (designated as HS-CRM8) that was designed in silico, as described 1,2. This HS-CRM8 contains evolutionary conserved clusters of transcription factor binding sites (TFBS) associated with high liver-specific gene expression. This expression cassette was cloned into a self-complementary (sc)AAV backbone 3. The vectors also contained a mini-intron from minute virus of mice (MVM) and a bovine growth hormone polyadenylation site (bGH polyA) (Figure 1). To generate the AAV-HS-CRM8-TTR-GFP vector the green fluorescent protein (GFP) gene was cloned downstream from HS-CRM8/TTR. Cloning details are available upon request.
منابع مشابه
Functions of the Heterologous Intron-Derived Fragments Intra and Extra Factor IX-cDNA Coding Region on the Human Factor IX Expression in HepG2 and Hek-293T Cells
Background: Human FIX (hFIX) gene transfer into hepatocytes has provided a novel approach for treatment of hemophilia B. To obtain an improved expression of hFIX, the functional hFIX-expressing plasmids with appropriate intron-derived fragments which facilitate transcription and promote an efficient 3′-end formation of mRNAs are required.Objectives: We ai...
متن کاملA David promoter with Goliath strength.
In this issue of Blood, Nair et al report on a computationally derived hepatocyte-specific cis-regulatory module (HS-CRM8) to accomplish high tissue-specific expression in gene therapy for hemophilia. When HS-CRM8 is introduced upstream of a minimal liver-specific promoter in an adenoassociated virus (AAV) that expresses a codon-optimized hyperactive human factor IX (FIX) mutant (FIX Padua), it...
متن کاملHyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy
The development of robust nonviral vectors could facilitate clinical gene therapy applications and may overcome some of the immune complications of viral vectors. Nevertheless, most nonviral gene deliver approaches typically yield only transient and/or low gene expression. To address these caveats, we have explored piggyBac transposons to correct hemophilia B by liver-directed factor IX (FIX) g...
متن کاملComputationally designed liver-specific transcriptional modules and hyperactive factor IX improve hepatic gene therapy.
The development of the next-generation gene therapy vectors for hemophilia requires using lower and thus potentially safer vector doses and augmenting their therapeutic efficacy. We have identified hepatocyte-specific transcriptional cis-regulatory modules (CRMs) by using a computational strategy that increased factor IX (FIX) levels 11- to 15-fold. Vector efficacy could be enhanced by combinin...
متن کاملFactors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
Long-term expression of coagulation factor IX (FIX) has been observed in murine and canine models following administration of recombinant adeno-associated viral (rAAV) vectors into either the portal vein or muscle. These studies were designed to evaluate factors that influence rAAV-mediated FIX expression. Stable and persistent human FIX (hFIX) expression (> 22 weeks) was observed from 4 vector...
متن کامل